191 related articles for article (PubMed ID: 20053395)
1. Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcepsilonRI-activated RBL-2H3 basophilic cells.
Sanderson MP; Gelling SJ; Rippmann JF; Schnapp A
Cell Immunol; 2010; 262(1):28-34. PubMed ID: 20053395
[TBL] [Abstract][Full Text] [Related]
2. Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: implications for regulation of IgE-mediated degranulation.
Sanderson MP; Wex E; Kono T; Uto K; Schnapp A
Mol Immunol; 2010; 48(1-3):171-8. PubMed ID: 20828828
[TBL] [Abstract][Full Text] [Related]
3. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
[TBL] [Abstract][Full Text] [Related]
4. ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of fcepsilon receptor I-mediated activation of Syk.
Moriya K; Rivera J; Odom S; Sakuma Y; Muramato K; Yoshiuchi T; Miyamoto M; Yamada K
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12539-44. PubMed ID: 9356485
[TBL] [Abstract][Full Text] [Related]
5. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.
Kepley CL
Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210
[TBL] [Abstract][Full Text] [Related]
6. Once phosphorylated, tyrosines in carboxyl terminus of protein-tyrosine kinase Syk interact with signaling proteins, including TULA-2, a negative regulator of mast cell degranulation.
de Castro RO; Zhang J; Groves JR; Barbu EA; Siraganian RP
J Biol Chem; 2012 Mar; 287(11):8194-204. PubMed ID: 22267732
[TBL] [Abstract][Full Text] [Related]
7. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
[TBL] [Abstract][Full Text] [Related]
8. Evidence for involvement of two isoforms of Syk protein-tyrosine kinase in signal transduction through the high affinity IgE receptor on rat basophilic leukemia cells.
Yamashita T; Kairiyama L; Araki M; Nagasawa S
J Biochem; 1998 Jun; 123(6):1199-207. PubMed ID: 9604011
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
Itoh T; Ninomiya M; Yasuda M; Koshikawa K; Deyashiki Y; Nozawa Y; Akao Y; Koketsu M
Bioorg Med Chem; 2009 Aug; 17(15):5374-9. PubMed ID: 19596200
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response.
Lin KC; Huang DY; Huang DW; Tzeng SJ; Lin WW
J Mol Med (Berl); 2016 Feb; 94(2):183-94. PubMed ID: 26373430
[TBL] [Abstract][Full Text] [Related]
11. The Src family kinase Fgr is critical for activation of mast cells and IgE-mediated anaphylaxis in mice.
Lee JH; Kim JW; Kim DK; Kim HS; Park HJ; Park DK; Kim AR; Kim B; Beaven MA; Park KL; Kim YM; Choi WS
J Immunol; 2011 Aug; 187(4):1807-15. PubMed ID: 21746961
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the tyrosine phosphorylation of Phospholipid Scramblase 1 in mast cells that are stimulated through the high-affinity IgE receptor.
Kassas A; Moura IC; Yamashita Y; Scheffel J; Guérin-Marchand C; Blank U; Sims PJ; Wiedmer T; Monteiro RC; Rivera J; Charles N; Benhamou M
PLoS One; 2014; 9(10):e109800. PubMed ID: 25289695
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
14. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
Braselmann S; Taylor V; Zhao H; Wang S; Sylvain C; Baluom M; Qu K; Herlaar E; Lau A; Young C; Wong BR; Lovell S; Sun T; Park G; Argade A; Jurcevic S; Pine P; Singh R; Grossbard EB; Payan DG; Masuda ES
J Pharmacol Exp Ther; 2006 Dec; 319(3):998-1008. PubMed ID: 16946104
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of xanthones isolated from the pericarp of Garcinia mangostana L. on rat basophilic leukemia RBL-2H3 cell degranulation.
Itoh T; Ohguchi K; Iinuma M; Nozawa Y; Akao Y
Bioorg Med Chem; 2008 Apr; 16(8):4500-8. PubMed ID: 18328716
[TBL] [Abstract][Full Text] [Related]
17. Intracellular single-chain variable fragments directed to the Src homology 2 domains of Syk partially inhibit Fc epsilon RI signaling in the RBL-2H3 cell line.
Dauvillier S; Mérida P; Visintin M; Cattaneo A; Bonnerot C; Dariavach P
J Immunol; 2002 Sep; 169(5):2274-83. PubMed ID: 12193692
[TBL] [Abstract][Full Text] [Related]
18. Activation of the high-affinity immunoglobulin E receptor Fc epsilon RI in RBL-2H3 cells is inhibited by Syk SH2 domains.
Taylor JA; Karas JL; Ram MK; Green OM; Seidel-Dugan C
Mol Cell Biol; 1995 Aug; 15(8):4149-57. PubMed ID: 7623809
[TBL] [Abstract][Full Text] [Related]
19. Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells.
Paolini R; Molfetta R; Beitz LO; Zhang J; Scharenberg AM; Piccoli M; Frati L; Siraganian R; Santoni A
J Biol Chem; 2002 Oct; 277(40):36940-7. PubMed ID: 12145291
[TBL] [Abstract][Full Text] [Related]
20. A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes.
Cha HS; Boyle DL; Inoue T; Schoot R; Tak PP; Pine P; Firestein GS
J Pharmacol Exp Ther; 2006 May; 317(2):571-8. PubMed ID: 16452391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
